TY  - CONF

T1  - Nab-paclitaxel or docetaxel as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): a cost utility analysis in five European countries

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2008/05/20

AU  - Dranitsaris G

AU  - Lidgren M

AU  - Lundkvist J

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1200/jco.2008.26.15_suppl.6571

VL  - 26

IS  - 15

Y2  - 2025/10/10

ER  -